The biopharmaceutical contract manufacturing market is projected to grow at a CAGR of 10%
With the advent of novel technologies and rising preference for such therapeutic interventions, biologics have made a significant impact in the pharmaceutical domain, delivering a ground-breaking treatment regimen for a myriad of disease indications.   London Roots Analysis has announced the addition of the “Biopharmaceutical Contract Manufacturing Market, 2022–2035”...
0 Comentários 0 Compartilhamentos 1291 Visualizações